Research Interests
Sexual reproduction and the emergence and evolution of microbial pathogens
Our studies focus on the human fungal pathogen Cryptococcus, which causes life-threatening infections of the central nervous system in both immunocompromised and immunocompetent hosts. This organism is a basidiomycete and therefore divergent from other common human fungal pathogens and model fungi. We contributed to define the sexual cycle involving haploid alpha anda cells, and to apply Falkow’s molecular postulates of virulence employing gene disruption approaches and robust animal virulence models. These efforts have defined the molecular basis for antifungal drug action and synergistic combinations and elucidated roles for calcineurin in fungal virulence and drug tolerance in C. neoformans, Candida albicans, and Aspergillus fumigatus. We are currently exploring the potential of combining calcineurin or Hsp90 inhibitors with existing antifungal agents against a panel of pathogenic fungi in infectious settings including systemic, ocular, and cutaneous models. We have participated in championing and organizing the fungal kingdom genome sequencing project. These efforts are nearly completed for five strains representing three related but divergent varieties of Cryptococcus, all of which are pathogenic in humans and have unique environmental and virulence attributes. In addition, we contributed to enlist the Broad Fungal Genome initiative to sequence a group of Candida species related to Candida albicans to explore their potential for sexual reproduction, including meiosis, and detailed molecular and genetic studies are in progress for the species Candida lusitaniaeon the functions of the mating type locus and conserved meiotic machinery. Finally, the fungal genome initiative of the Department of Energy Joint Genome Institute is currently sequencing the basidiomycete Tremella mesenterica, and Keisha Findley in our group serves as the community coordinator for this genome project.
Parallel studies have focused on the structure, function, and evolution of the fungal mating type locus, which is linked to differentiation and virulence potential in Cryptococcus. Signaling cascades that control virulence and mating have been defined, and the a and alpha alleles of the mating type locus have been cloned and sequenced from two varieties and the sibling species C. gattii. The MAT locus spans over 100 kb and contains more than 20 genes, several of which function in differentiation and virulence. The MAT alleles are composed of divergent sets of the same genes that evolved by extensive remodeling from a common ancestral DNA region. The only MAT allele specific genes encode two homeodomain proteins, Sxi1alpha and Sxi2a, which physically interact and are necessary and sufficient to govern post-fusion events enabling completion of the sexual cycle. A detailed model has been developed for the evolution of MAT from an ancestral tetrapolar mating system, revealing parallels with the evolution and features of sex chromosomes of plants and animals. We have contributed to define the structure of the mating type locus from the human dimorphic fungal pathogens, Histoplasma capsulatum, Coccidioides immitis and C. posadasii, revealing that all three retain both mating types, consistent with extant sexual cycles that remain to be explored. These studies also reveal how genes have been captured into the MAT locus, with implications for expansions of MAT that have occurred in other pathogenic fungi, including C. albicans and C. neoformans and C. gattii. Finally, we have defined the structure of the mating type locus in Phycomyces blakesleeanus, the first representative of the Zygomycete phylum in which MAT has been identified. This reveals that the sexM andsexP loci each contain only a single gene, and each encodes a divergent HMG domain transcription factor homolog, with implications for the origins of sex determination and the evolution of sex chromosomes.
We have defined the sexual cycles for the most common pathogenic variety of Cryptococcus (serotype A, variety grubii), recapitulated the sexual cycle for the divergent gattii variety that infects immunocompetent hosts with implications for an unusually fertile clonal alpha isolate causing an outbreak on Vancouver Island, and contributed to the discovery of a unique population of serotype A strains undergoing active recombination in sub-Saharan Africa. Recent studies have demonstrated that sexual reproduction occurs on Pigeon guano medium, and during a pathogenic association with plants, two common environmental niches in which Cryptococcus may complete its sexual cycle in nature to produce infectious spores. Our studies reveal an enhanced virulence potential of alpha strains during co-infection with a strains, and the molecular basis for this enhanced virulence is being explored involving pheromone production and sensing via cell-cell signaling analogous to quorum sensing in bacteria and other fungi. This model is being examined in detail in both murine virulence models and in heterologous hosts, including insects. Our investigations have revealed that monokaryotic fruiting represents a modified form of the sexual cycle that can occur between partners of only one mating type, and which involves a ploidy shift, meiosis, and production of recombinant haploid progeny that may represent the infectious propagules. Recent population genetic studies implicate this laboratory defined same sex mating cycle in the origin and ongoing outbreak of Cryptococcus gattii on Vancouver Island. In collaboration with Kieren Marr, we have identified the first index case for expansion of the Vancouver Island outbreak into the United States, and further studies of environmental, veterinary, and human isolates are ongoing. Our studies of unusual hybrid isolates of Cryptococcus neoformans(alphaADalpha) demonstrate that same sex mating occurs in nature and has given rise to hybrids which exhibit hybrid fitness and are pathogenic. Analysis of a different hybrid lineage (aADalpha) provides evidence that these isolates descend from a mating event in sub-Saharan Africa that gave rise to a hybrid that emigrated worldwide and is a common cause of infection. Taken together, these complementary lines of investigation illustrate the potential roles of sexual recombination in the evolution and virulence of a species cluster of human fungal pathogens with implications for other eukaryotic microbial pathogens, including fungi, parasites, and bacterial pathogens.
E Pluribus Unum: The Fungal Kingdom as a Rosetta Stone for Biology and Medicine.
How Model and Pathogenic Fungi Sense the Environment and the Host
Sex and the evolution of microbial pathogens
Sex and emerging pathogens- Vancouver Island Cryptococcus gattii outbreak expands
Evolution of Gene Clusters: The Mating Type Locus Paradigm
Antifungal Drug Action and the Elucidation of Drug Targets in Fungi
Read an article presenting Dr. Heitman’s reflections on the MD-PhD program and the importance of discovery and serendipity in science. Read more (Originally published: Beyond the Bench, The Rockefeller University, February 1993)
On the discovery of TOR as the Target of Rapamycin, Science Matters Series, PLOS Pathogens, Joseph Heitman
Weill Cornell Medicine Magazine on the Lasker Prize for the Discovery of TOR as the Target of Rapamycin by Joseph Heitman, Rao Movva, and Michael Hall
Medical Mycological Society of the Americas (MMSA) Rhoda Benham award talk 2018
Medical Mycological Society of the Americas (MMSA) banquet Rhoda Benham Dinner Talk – June 9, 2018
Selected Grants
Tri-Institutional Molecular Mycology and Pathogenesis Training Program
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029Calcineurin signaling cascades governing Cryptococcus virulence
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2028The Genetic Basis of Virulence in Cryptococcus Neoformans
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2017 - 2028Duke Preparing Research Scholars in Biomedical Sciences- Post-Baccalaureate Research Education Program
Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 2022 - 2027RNAi-dependent epimutation roles in antimicrobial drug resistance and pathogenesis
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Medical Scientist Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institute of General Medical Sciences · 2022 - 2027Training Program in Developmental and Stem Cell Biology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2001 - 2027Cell and Molecular Biology Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026Impact of RNAi and unisexual reproduction on Cryptococcus evolution, drug resistance, and pathogenesis
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 1997 - 2026Fungal Kingdom: Threats & Opportunities
ResearchPrincipal Investigator · Awarded by Canada Institute for Advanced Research · 2019 - 2026Malassezia and Candida auris: skin microbiome dysbiosis and de-regulation of cutaneous homeostasis
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2026Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025Genetic and Genomics Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025Structure, function, and evolution of the Cryptococcus MAT locus
ResearchPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2002 - 2025Therapeutic Agents Targeting Cryptococcal Infections
ResearchPrincipal Investigator · Awarded by Quercus Molecular Design · 2023 - 2025Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Unified Program for Therapeutics in Children
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2019 - 2024Implications of mycoviral infection in Talaromyces marneffei: an analysis of human patient samples, RNAi, and hypermutation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2023Structural Biological Development of Fungal-Specific Calcineurin Inhibitors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2022Causes and Consequences of Hypermutability in Cryptococcus neoformans
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2022Medical Scientist Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1997 - 2022Structure-guided development of fungal specific calcineurin inhibitors
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022Discovering novel antifungal agents via multi-species profiling of a structurally and stereochemically diverse, well-validated compound library
ResearchPrincipal Investigator · Awarded by Broad Institute · 2019 - 2021Mining the Coprophilous Mycobiome for new Cryptococcus Antiinfectives and Antifungal Synergists
ResearchCollaborator · Awarded by University of Iowa · 2017 - 2020Genetics Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1979 - 2020Organization and Function of Cellular Structure
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2020Temperature-dependent transposon mobilization in Cryptococcus neoformans
ResearchConsultant · Awarded by National Institutes of Health · 2017 - 2020Mechanism to evade host immunity by Mucorales fungi
ResearchCollaborator · Awarded by National Institutes of Health · 2018 - 2020Thermo Lumos Tribrid High-Resolution Accurate-Mass Tandem Mass Spectrometer
EquipmentMajor User · Awarded by National Institutes of Health · 2018 - 2019Structural Biological Development of Fungal-Specific Calcineurin Inhibitors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2019Duke Research Training Program for Pediatricians
Inst. Training Prgm or CMETraining Faculty · Awarded by National Institutes of Health · 2002 - 2018Center for Molecular & Cellular Studies of Ped Disease
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2003 - 2018The Genetic Architecture of Virulence in Cryptococcus Neoformans
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2017 - 2017Institutional Training Grant in Pediatric Infectious Disease
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2011 - 2016A Computer Modeling Approach to Create an Antifungal to Improve the Treatment of Cryptococcal Infections
ResearchPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2014 - 2016Improvement of genetic analysis in the pathogenic zygomycete Mucor circinelloides
ResearchCo Investigator · Awarded by National Institutes of Health · 2016 - 2016A Combination Therapy Approach to Treating Drug Resistant Fungal Infections
ResearchPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2014 - 2016Cancer Biology Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Cancer Institute · 1993 - 2016Clinical Oncology Research Career Development Program
ResearchMentor · Awarded by National Institutes of Health · 2009 - 2015Instrumentation for Quantitative Phosphoproteomics and Acetylomics
EquipmentMajor User · Awarded by National Institutes of Health · 2014 - 2015Novel Antifungal Therapeutic Approaches
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2014A Computer Modeling Approach to Create an Antifungal to Improve the Treatment of Cryptococcal Infections
ResearchPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2012 - 2014A Structural Approach for Treating Drug Resistant Fungal Pathogens
ResearchPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2012 - 2014Pulmonary Surfactant and Lung Homeostasis
ResearchCollaborator · Awarded by National Institutes of Health · 1993 - 2014Sexual reproduction and virulence of zygomycete fungi
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2010 - 2013Role of Calcineurin in Fungal Virulence
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2004 - 2010Genetic analysis of Cryptococcus neoformans virulence
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2005 - 2010GPCR signaling cascades in Cryptococcus neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2009Genetic molecular biology of virulence in C. neoformans
ResearchCo Investigator · Awarded by National Institutes of Health · 1991 - 2008Same
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1998 - 2003Same
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1997 - 2001Novel Antifungal Drug Targets In Cryptococcus Neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1997 - 1999Immunosuppressant Targets In Cryptococcus Neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1997 - 1999External Relationships
- CIFAR
- Yonsei University Seoul Korea
- stock owned in a variety of companies, about $300,000 total in about 60 different companies
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.